Casein kinase 1δ-IN-8

CAS No. 851396-73-1

Casein kinase 1δ-IN-8( —— )

Catalog No. M37072 CAS No. 851396-73-1

Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 42 In Stock
25MG 70 In Stock
50MG 102 In Stock
100MG 152 In Stock
200MG 220 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Casein kinase 1δ-IN-8
  • Note
    Research use only, not for human use.
  • Brief Description
    Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.
  • Description
    Casein kinase 1δ-IN-8 (compound 494) is an inhibitor of Casein kinase 1δ, Casein kinase 1δ-IN-8 can be used in the treatment of neurodegenerative disorders such as Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    Casein Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    851396-73-1
  • Formula Weight
    379.41
  • Molecular Formula
    C19H14FN5OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(CC(=O)C1=CC=CN1)C=2N(C(=NN2)C=3C=CN=CC3)C4=CC=C(F)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sheridan, Joseph M, et, al. Casein kinase 1δ inhibitors for the treatment of neurodegenerative disorders. WO2012080729 A2 2012-06-21.
molnova catalog
related products
  • SSTC3

    SSTC3 is a novel small-molecule CK1α activator with EC50 of 30 nM (WNT-driven reporter gene assay), Kd of 32 nM.

  • Ellagic Acid hydrate

    Ellagic acid hydrate is a natural antioxidant and acts as a potent and ATP-competitive CK2 inhibitor (IC50:40 nM Ki: 20 nM).

  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).